Oritavancin

£25,000.00

Introducing Oritavancin, a potent lipoglycopeptide antibiotic used to treat acute bacterial skin and skin structure infections, including those caused by difficult-to-treat MRSA strains. This powerful single-dose intravenous treatment offers a complete course of therapy, enhancing patient adherence and streamlining hospital workflows. Its rapid action and efficacy against resistant gram-positive organisms represent a significant advantage in infectious disease management, helping to combat the growing threat of antimicrobial resistance. Oritavancin ensures clinical efficiency and superior patient outcomes with its unique triple mechanism of action, making it a critical asset in modern healthcare settings.

Description

1. Product Overview

Oritavancin is a potent lipoglycopeptide antibiotic designed for targeted bacterial inhibition. It is primarily utilized in pharmaceutical manufacturing for the treatment of serious Gram-positive infections, including complicated skin and soft tissue infections. Its unique mechanism of action and long half-life provide superior efficacy compared to conventional glycopeptides, making it a critical asset in therapeutic formulations. Strategically, Oritavancin addresses high-demand antimicrobial markets, ensuring both clinical relevance and commercial value for industrial pharmaceutical producers.

2. Key Specifications & Technical Characteristics

  • Chemical Composition: C₈₉H₁₀₇Cl₂N₁₇O₂₇ (lipoglycopeptide structure)
  • Purity Level: ≥ 98% (HPLC grade)
  • Physical Form: White to off-white crystalline powder
  • Solubility: Soluble in DMSO, methanol; slightly soluble in water
  • Melting Point: 280–285°C (decomposition)
  • Packaging Options: 1 kg, 5 kg, 10 kg HDPE drums; customized bulk options available
  • Shelf Life: 24 months under recommended storage conditions (2–8 °C, protected from light)

3. Core Industrial Applications

  • Primary Industries: Pharmaceutical manufacturing, contract research organizations (CROs), biotechnology firms
  • Operational Use Cases:
    • Formulation of injectable antibiotics
    • Active pharmaceutical ingredient (API) supply for sterile dosage forms
    • Research & development for next-generation antimicrobial agents
  • Performance Advantages:
    • Long-acting antimicrobial effect reduces dosing frequency
    • High chemical stability under standard formulation conditions
    • Superior potency against multi-drug resistant Gram-positive bacteria, enhancing product differentiation

4. Competitive Advantages

  • Quality Consistency: Produced under cGMP standards ensuring batch-to-batch uniformity
  • Supply Reliability: Stable production with scalable output for large industrial orders
  • Logistics Capability: Global shipping compliance with pharmaceutical-grade handling
  • Price Competitiveness: Optimized cost structure for bulk procurement
  • Sustainability: Produced with minimal solvent waste and energy-efficient processes
  • Technical Support: Comprehensive documentation, including certificates of analysis (CoA) and material safety data sheets (MSDS)

5. Commercial & Supply Information

  • Minimum Order Quantity (MOQ): BULK 20 MT
  • Loading Capacity: Up to 20 MT per standard 20 ft container

Reviews

There are no reviews yet.

Be the first to review “Oritavancin”

Your email address will not be published. Required fields are marked *

Add to cart